1. 1465PPhase I dose escalation of pembrolizumab given concurrently with palliative thoracic radiotherapy (RT) for NSCLC. (23rd October 2018) Authors: Kumar, R; Walder, D P; Pejanaute, A; Gunapala, R; Bhosle, J; Yousef, N; Popat, S; McDonald, F; Locke, I; Harrington, K; Tree, A; Lalondrelle, S; Huddart, R; O'Brien, M E R; Ahmed, M Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Clinical management and research priorities for high-risk prostate cancer in the UK: Meeting report of a multidisciplinary panel in conjunction with the NCRI Prostate Cancer Clinical Studies Localised Subgroup. (November 2016) Authors: Gnanapragasam, VJ; Hori, S; Johnston, T; Smith, D; Muir, K; Alonzi, R; Winkler, M; Warren, A; Staffurth, J; Khoo, V; Tree, A; Macneill, A; McMenemin, R; Mason, M; Cathcart, P; de Souza, N; Sooriakumaran, P; Weston, R; Wylie, J; Hall, E Journal: Journal of clinical urology Issue: Volume 9:Number 6(2016:Nov.) Page Start: 369 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗